129 related articles for article (PubMed ID: 30076020)
21. Intraocular Relapse with Hypopyon and Retinal Infiltrates after Chemotherapy and Peripheral Blood Stem Cell Transplantation for Extranodal NK/T-Cell Lymphoma.
Matsuo T; Tanaka T; Ichimura K; Meguri Y
J Clin Exp Hematop; 2015; 55(3):157-61. PubMed ID: 26763364
[TBL] [Abstract][Full Text] [Related]
22. Primary laryngeal NK/T-cell non-Hodgkin lymphoma: a case report.
Cikojević D; Gluncić I; Pesutić-Pisac V; Klancnik M; Colović Z
Ear Nose Throat J; 2012 Jul; 91(7):E10-2. PubMed ID: 22829038
[TBL] [Abstract][Full Text] [Related]
23. Primary laryngeal T/NK-cell lymphoma, nasal-type: an unusual location for an aggressive subtype of extranodal lymphoma.
Tardío JC; Moreno A; Pérez C; Hernández-Rivas JA; López-Carreira M
Eur Arch Otorhinolaryngol; 2008 Jun; 265(6):705-8. PubMed ID: 17955253
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
25. Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population.
Ghione P; Qi S; Imber BS; Seshan V; Moskowitz A; Galasso N; Lunning M; Straus D; Sauter C; Dahi P; Dogan A; Yahalom J; Horwitz S
Leuk Lymphoma; 2020 Dec; 61(14):3331-3341. PubMed ID: 32844695
[TBL] [Abstract][Full Text] [Related]
26. [Laryngotracheal NK/T lymphoma: clinical case].
de la Rosa Astacio F; Barberá Durbán R; Vaca González M; Cobeta Marco I
Acta Otorrinolaringol Esp; 2011; 62(1):71-3. PubMed ID: 20307871
[TBL] [Abstract][Full Text] [Related]
27. Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Michot JM; Mazeron R; Danu A; Lazarovici J; Ghez D; Antosikova A; Willekens C; Chamseddine AN; Minard V; Dartigues P; Bosq J; Carde P; Koscielny S; De Botton S; Ferme C; Girinsky T; Ribrag V
Eur J Cancer; 2015 Nov; 51(16):2386-95. PubMed ID: 26254810
[TBL] [Abstract][Full Text] [Related]
28. Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation.
McEachron TA; Kirov I; Wungwattana M; Cortes D; Zabokrtsky KB; Sassoon A; Craig D; Carpten JD; Sender LS
Pediatr Blood Cancer; 2016 Apr; 63(4):727-30. PubMed ID: 26727971
[TBL] [Abstract][Full Text] [Related]
29. [A rare endolaryngeal tumor].
Ngo C; Albert S; Barry B; Copie-Bergman C; Couvelard A; Hourseau M
Ann Pathol; 2017 Oct; 37(5):420-424. PubMed ID: 28964599
[TBL] [Abstract][Full Text] [Related]
30. [Extra-nodal NK/T-cell lymphoma, nasal type presenting as orbital cellulitis].
Amri GE; Zalagh M; Benariba F
Pan Afr Med J; 2018; 31():8. PubMed ID: 30918537
[TBL] [Abstract][Full Text] [Related]
31. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
[TBL] [Abstract][Full Text] [Related]
32. Primary NK/T-cell lymphoma of the larynx.
Uri N; Schindler Y; Quitt M; Valkovsky O; Barzilai G
Ear Nose Throat J; 2012 May; 91(5):206-7. PubMed ID: 22614556
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Kim HJ; Ock CY; Kim TM; Lee SH; Lee JY; Jung SH; Cho YS; Kim M; Keam B; Kim DW; Kim IH; Heo DS
Cancer Res Treat; 2018 Jul; 50(3):670-680. PubMed ID: 28675023
[TBL] [Abstract][Full Text] [Related]
34. Five-year analysis from phase 2 trial of "sandwich" chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
Zhang L; Jiang M; Xie L; Zhang H; Jiang Y; Yang QP; Liu WP; Zhang WY; Zhuo HY; Li P; Chen NY; Zhao S; Wang F; Zou LQ
Cancer Med; 2016 Jan; 5(1):33-40. PubMed ID: 26633585
[TBL] [Abstract][Full Text] [Related]
35. Current and future management of NK/T-cell lymphoma based on clinical trials.
Yamaguchi M
Int J Hematol; 2012 Nov; 96(5):562-71. PubMed ID: 23073619
[TBL] [Abstract][Full Text] [Related]
36. Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Suzuki R
Int J Hematol; 2010 Dec; 92(5):697-701. PubMed ID: 21116747
[TBL] [Abstract][Full Text] [Related]
37. A five
Vittayawacharin P; Khuhapinant A
Hematology; 2021 Dec; 26(1):75-82. PubMed ID: 33427594
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
[TBL] [Abstract][Full Text] [Related]
39. Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Celentano A; Mascolo M; Cirillo N; De Rosa G; Mignogna MD
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):381-384. PubMed ID: 28061034
[TBL] [Abstract][Full Text] [Related]
40. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]